transaction to invest in the common stock of BS Myco Biotech Company Limited that operate in the Biopharmaceutical products with purchase from Bangjak Green Energy Company Limited total 399,990 shares or 85.65
ท่ี 10000000/008/62 วนัท่ี 22 มกราคม 2562 เร่ือง แจง้มติท่ีประชุมคณะกรรมการบริษทั เก่ียวกบัการเขา้ลงทุนในโครงการ Energy Recovery Unit โดยการเขา้ซ้ือ หน่วยผลิตไฟฟ้า (Energy Recovery Unit) จากบริษทั
unrealized foreign exchange gain amounting of THB 239.5 mm. However, considering only the share of profits from investment in associated companies from power business, excluding such unrealized gain on foreign
decreased 71.84%. Net profit For the nine-month period ended 30 September 2019, the Company and its subsidiaries had net profits of THB 202.58 million, an increase of THB 20.87 million or 11.49% from the same
equivalent to 18.2% over the same period last year, due primarily to the decrease of profit from Central DFS and Central Marketing Group in Thailand and Malaysia , partially offset by an increase in profits
, profit from the debt reduction by the creditor, and other profits. 2 Information is retrieved from the cash flow statement. Information from the Consolidated Financial Statements of the Company for the
3.72 Remark 1 Operating revenue excludes profit from the debt restructuring, profit from the debt reduction by the creditor, and other profits. 2 Information is retrieved from the cash flow statement
issue in academic system. In addition, the decline was due to a decrease in share of profits from Le Cordon Bleu Dusit, netted off a decrease in share of loss from investment in Dusit Hospitality
– 36.7 = (127.4) million baht Attachment 1 Page 6/11 (2) Calculation based on net operating profits Not applicable as the Company incurred a loss. (3) Calculation based on total value of consideration paid